Jamjoom Pharma hits highest price since debut
Shares of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) hit an all-time high today, Aug. 11, at SAR 166.80.
The stock closed 1% lower at SAR 159.80 as about 230,000 shares changed hands.
Year High (SAR) | Year Low (SAR) |
166.80 | 100.20 |
Highest Since Debut (SAR) | Lowest Since Debut (SAR) |
166.80 | 66.00 |
Market Data :
Open | 150.60 |
Low | 148.50 |
High | 150.60 |
Previous Close | 150.60 |
Change (3M) | (13.25 %) |
Change (6M) | (3.46 %) |
Market Value | 10,395.00 |
Avg. Volume (3M) | 55,043.83 |
Avg. Turnover (3M) | 9,146,705.14 |
Avg. Transaction (3M) | 1,163.82 |
Change(12M) | (21.73 %) |
YTD | (1.05 %) |
Jamjoom Pharma has not amended its capital since listing on the Saudi Exchange (Tadawul) on June 20, 2023.
Adjustments to the capital (M Riyal) :
Date | Type | Capital (M Riyal) | Change (%) |
2023 | IPO | 700.00 | 0.00% |
Financial Performance :
Overview :
Established as a branch of Abdullatif Mohammed Salah Jamjoom and Brothers Company in Jeddah in 1994, the company began commercial operations at its main facility in Jeddah in 2000. Following its conversion into a limited liability company in 2004, the company embarked on a period of significant growth and development.
Key milestones included the launch of "Unifresh" in 2012, the first standardized dose product produced using airtight manufacturing technology and packaging. In 2013, th...
Comments {{getCommentCount()}}
Be the first to comment
{{Comments.indexOf(comment)+1}}
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}

Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.
Financial Ratios :
Financial Ratio | Current |
Market Cap (M Riyal) | 10,409.01 |
Shares Outstanding ((M)) | 70.00 |
EPS ( | ) (TTM)6.22 |
Book Value (BV) ( Riyal) (Latest announcement) | 24.03 |
Recurring P/E | 23.88 |
Price/book | 6.19 |
Dividend Yield (%) (Last Year) | 2.06 |
Return on Average Assets (%) (TTM) | 22.36 |
Return on Average Equity (%) (TTM) | 27.70 |
Par Value ( Riyal) | 10.00 |
Enterprise Value (EV) (M Riyal) | 10,225.12 |
EV/adj EBITDA | 21.25 |
EV/Revenues | 7.10 |
Calendar :
-
15 August
Ex-dividend Date
- -
25 August
Cash Dividend Distribution
- -
27 October
Conferences
- -
27 October
Financial results date
- -
19 February
General Assembly
- -
04 March
Ex-dividend Date
-
Analyst Estimates :
156.86
Fair Average Price
1
Number of Recommendations
Rating | Research firm | Current Price | Target Price | Change | |
Buy | United Securities Company | 136.80 | 156.86 | 14.66 % |
Call Request
Comments Analysis: